Latest Articles

Multiple Myeloma

Emerging Prognostic Markers Continue to Improve Myeloma Treatment

Emerging Prognostic Markers Continue to Improve Myeloma Treatment

Newly-discovered and future biomarkers are likely to help oncologists give an accurate prognosis and to prescribe more effective treatment for patients with multiple myeloma.

Chronic Myeloid Leukemia Combined Treatment May Lead to Cure for Chronic Myeloid Leukemia

Combined Treatment May Lead to Cure for Chronic Myeloid Leukemia

Study "opens the possibility" to "convert partial responses into real cures."

Breast Cancer Q&A With Dr Sarah Vinnicombe: Use Breast MRI Judiciously for Optimal Outcomes

Q&A With Dr Sarah Vinnicombe: Use Breast MRI Judiciously for Optimal Outcomes

CTA interviewed Dr Sarah Vinnicombe about her recent article on the role of breast MRI for breast cancer staging and screening.

General Oncology Ghost and Honorary Authorship in Cancer Research

Ghost and Honorary Authorship in Cancer Research

Despite widespread stigma and efforts to limit prevalence, ghost and honorary authorship remain widespread in clinical trials.

Lung Cancer Immune Checkpoint Inhibitors Continue to Transform Management of Advanced NSCLC

Immune Checkpoint Inhibitors Continue to Transform Management of Advanced NSCLC

Immunotherapy may be effective for some patients with NSCLC as a second-line treatment, but it's unclear the role it will have in the first-line.

Renal Cell Carcinoma Treating TKI-induced Hypertension in Renal Cell Carcinoma

Treating TKI-induced Hypertension in Renal Cell Carcinoma

Inhibiting the VEGF signaling pathway can cause hypertension; there are, however, limited data on managing kinase inhibitor-induced hypertension.

Multiple Myeloma Minimal Residual Disease and Treatment Response in Multiple Myeloma

Minimal Residual Disease and Treatment Response in Multiple Myeloma

A newly released survey of clinical testing finds that widely divergent methodologies for MRD testing remain a continuing challenge.

General Oncology 2016 Concordia Summit: The Future of Immunotherapy

2016 Concordia Summit: The Future of Immunotherapy

Speakers at the 2016 Concordia Summit's panel, "Precision Medicine in Cancer Research," discussed the importance and future of immunotherapy for cancer treatment.

General Oncology Q&A With Dana Carroll, PhD, Highlights CRISPR's Growing Role in Genome Editing

Q&A With Dana Carroll, PhD, Highlights CRISPR's Growing Role in Genome Editing

In this question-and-answer session, CTA asked Dr Carroll about CRISPR-Cas9, the state of the science of genome editing, and its implications for oncology.

Side Effect Management Assessing Mindfulness-based Cognitive Therapy For Cancer Pain

Assessing Mindfulness-based Cognitive Therapy For Cancer Pain

Researchers are attempting to determine the usefulness of mindfulness for cancer pain.

General Oncology The Evolutionary Implications of CRISPR-Cas9 for Clinical Oncology

The Evolutionary Implications of CRISPR-Cas9 for Clinical Oncology

CRISPR is receiving attention as a gene-editing tool that may help us treat cancer, but evolutionary theory suggests a much more complex reality.

General Oncology Enforcing Reproducibility Improves the Accuracy of Scientific Predictions

Enforcing Reproducibility Improves the Accuracy of Scientific Predictions

Overselling scientific data contributes to misunderstanding, failure, and disappointment in real-world settings.

Pancreatic Cancer Endoscopic Ultrasound and Pancreatic Cancer Screening

Endoscopic Ultrasound and Pancreatic Cancer Screening

Many studies show that EUS has a significant benefit over risk ratio, although more data is needed to fully understand the potential of EUS in screening for pancreatic cancer.

Renal Cell Carcinoma Combination Immunotherapy Promising for Treatment of Renal Cell Carcinoma

Combination Immunotherapy Promising for Treatment of Renal Cell Carcinoma

Novel targeted and immunological therapies may help improve the outlook for patients with renal cell carcinoma (RCC).

Lung Cancer Checkpoint Inhibitors and Combination Therapy: the Future of Treatment for Non-small Cell Lung Cancer?

Checkpoint Inhibitors and Combination Therapy: the Future of Treatment for Non-small Cell Lung Cancer?

While immune checkpoint inhibitors show real promise for treating lung cancer, better predictive biomarkers are necessary to make the therapy more effective.

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs

Sign Up for Free e-newsletters